Peginterferon alfa-2a Subcutaneous and Severe hepatic disease
Result of checking the interaction of drug Peginterferon alfa-2a Subcutaneous and disease Severe hepatic disease for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of peginterferons alfa are contraindicated in patients with hepatic decompensation (Child-Pugh score greater than 6, class B or C) in cirrhotic patients before treatment, and in patients with hepatic decompensation (Child-Pugh score greater or equal to 6) that have chronic hepatitis C coinfected with HIV.
Generic Name: peginterferon alfa-2a
Brand Name: Pegasys, Pegasys ProClick Autoinjector, Pegasys Prefilled Syringe
Synonyms: Peginterferon alfa-2a, Peginterferon Alfa-2a